Our hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement treatment efficacy when compared to patients with chronic pain managed with oral or systemic opioid therapies. Our secondary hypothesis is that patients with intrathecal delivery systems for chronic non-cancer pain will report no improvement in treatment efficacy when compared to patients with chronic pain who are managed with non-opioid therapies.
Study Type
OBSERVATIONAL
Enrollment
125
Brigham and Women's Hospital
Boston, Massachusetts, United States
Treatment Efficacy of Intrathecal Infusions
The primary objective of this study is to evaluate the treatment efficacy of intrathecal infusions for chronic pain and compare this form of therapy to systemic opioid therapy and non-opioid therapy for chronic pain \> 6 months duration.
Time frame: March 2014
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.